I called GreenLeaf Health at 8:30 A.M. CST today and spoke with Heather Rosencrans. I asked if she could confirm that they were working with ADMD and if so, if any updates could be provided on FDA progress. I was told that Greenleaf works under a non-disclosure agreement and that they are not able to release information on what clients they work with nor any updates related to those clients without written authorization from the client.
Way to inspect what you expect. If Jim is going to provide this information why not run with it and investigate further? Were you ever an investigative journalist? I still think an article on SA or somewhere would be great!
Lots of greyed out posts. You must have stirred up those psychotic lying idiots on Team Ignore (Paid posters).
For people wondering about how Greenleaf was mentioned, rewind the board 4-6 months and look at the posts. Also, for people wondering about certain company information, pick up the phone and call them. Simple. If you are an investor in ADMD, you own part of the company, vis a vis, you have a right to ask questions about the state and health of the company that you own. If they cannot answer them due to regulations, then they will tell you that.
Good deal Shekels. It's highly unlikely that AMIC or its partners would release any information over the phone, but good try. I think at this point we'll have to wait for an 8K and hope that AMIC gives answers to some of the questions that all of us have. As I've alluded to before, I think AMIC is a little information gun shy after the false predictions and expections of FDA clearance earlier this year. I actually do agree that AMIC should wait for something definitive and of substance before they release news. It would be nice to have a CC though. MDLAND~
What I find very interesting is that you spoke with Kartzoff and he told you that he was in fact working with Greenleaf, but you still decided to call them and ask if that was true. That speaks volumes for how much trust and confidence he instilled in you during the call. That guy provides no value and a lot of baggage to the company.